We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
United Airlines
UAL
$42.1B
| $165M | 0.38% |
1,870,272
+434,148
| +30% | +$39M |
|
52
Lockheed Martin
LMT
$136B
| $165M | 0.38% |
423,090
+162,047
| +62% | +$62.2M |
|
53
Lincoln National
LNC
$8.81B
| $159M | 0.37% |
2,698,281
+284,000
| +12% | +$16.7M |
|
54
SBA Communications
SBAC
$19.5B
| $152M | 0.35% |
630,029
-67,233
| -10% | -$15.9M |
|
55
Alibaba
BABA
$308B
| $149M | 0.35% |
701,682
+179,407
| +34% | +$33.7M |
|
56
Ford
F
$55.7B
| $147M | 0.34% |
15,845,784
+1,768,350
| +13% | +$15.9M |
|
57
Delta Air Lines
DAL
$60.1B
| $146M | 0.34% |
2,495,299
+1,285,059
| +106% | +$72.1M |
|
58
Genpact
G
$5.81B
| $143M | 0.33% |
3,402,084
-691,626
| -17% | -$27.6M |
|
59
Amdocs
DOX
$6.22B
| $142M | 0.33% |
1,965,467
+368,839
| +23% | +$25.1M |
|
60
Public Storage
PSA
$61.3B
| $141M | 0.33% |
659,873
+191,514
| +41% | +$42.5M |
|
61
Philips
PHG
$26.1B
| $135M | 0.31% |
3,485,866
-650,146
| -16% | -$23.5M |
|
|
NBIS
62
Nebius Group N.V.
NBIS
$47.7B
| $133M | 0.31% |
3,052,794
+1,040,451
| +52% | +$38.8M |
|
63
Ulta Beauty
ULTA
$24.3B
| $132M | 0.31% |
522,962
-79,527
| -13% | -$19.4M |
|
64
Check Point Software Technologies
CHKP
$13.1B
| $131M | 0.31% |
1,182,585
-63,595
| -5% | -$7.15M |
|
65
lululemon athletica
LULU
$14.6B
| $131M | 0.3% |
563,467
-137,957
| -20% | -$29.4M |
|
66
Edwards Lifesciences
EW
$51.7B
| $127M | 0.3% |
+1,637,208
| New | +$128M |
|
67
Smith & Nephew
SNN
$12.6B
| $127M | 0.3% |
2,644,320
-658,504
| -20% | -$29.7M |
|
68
Copart
CPRT
$27.5B
| $126M | 0.29% |
5,529,992
+857,636
| +18% | +$18.3M |
|
69
Ameriprise Financial
AMP
$48.8B
| $125M | 0.29% |
750,711
-474,212
| -39% | -$73.5M |
|
70
Canadian National Railway
CNI
$76.6B
| $124M | 0.29% |
1,374,887
-2,364,631
| -63% | -$213M |
|
71
Skyworks Solutions
SWKS
$10.6B
| $123M | 0.29% |
1,020,011
+318,813
| +45% | +$31.3M |
|
72
Johnson Controls International
JCI
$92.2B
| $119M | 0.28% |
2,927,308
+2,857,959
| +4,121% | +$121M |
|
73
Unum
UNM
$14.3B
| $119M | 0.28% |
4,086,449
+377,059
| +10% | +$11M |
|
74
Gilead Sciences
GILD
$165B
| $116M | 0.27% |
1,790,192
+14,088
| +0.8% | +$917K |
|
75
Fortinet
FTNT
$117B
| $115M | 0.27% |
5,404,905
-2,600,120
| -32% | -$48.9M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.